Sort
82,697 grants matching “vaccine development”
Ecopathogenomics of sexually transmitted infections (EPSTI)
$2,479,885Patrik M Bavoil · University Of Maryland Baltimore · U19 · FY2014 · AI
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,479,615Steven Foung · Stanford University · U19 · FY2023 · AI
ETIB Clinical Research Core
$2,479,411Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2011 · CA
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
$2,479,201Robert A Britton · Baylor College Of Medicine · U19 · FY2025 · AI
SPORE IN BREAST CANCER
$2,478,775University Of Alabama At Birmingham · P50 · FY2000 · CA
Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine
$2,478,197Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI
Nonhuman Primate (NHP) Core Functional Genomics Laboratory for AIDS Vaccine Research and Development
$2,477,909Michael Gale · University Of Washington · N01 · FY2021 · AI
TAS::75 0885::TAS NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,477,572Norman L Letvin · Beth Israel Deaconess Medical Center · N01 · FY2010 · AI
Tissue compartmentalization of human lymphocytes
$2,476,957Donna L Farber · Columbia University Health Sciences · P01 · FY2015 · AI
PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)
$2,476,466Lori Sokoll · Johns Hopkins University · N01 · FY2019 · AI
COMBINATION IMMUNIZATION AS AN APPROACH TO AIDS VACCINES
$2,475,278University Of Washington · P01 · FY2000 · AI
Regional Biocontainment Laboratory
$2,475,000Charles L Bailey · George Mason University · UC6 · FY2007 · AI
Continued Development of a Recombinant Vaccine (RivaxTM) against Ricin Toxin
$2,474,641Robert Newton Brey · Soligenix, Inc. · U01 · FY2006 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$2,474,435Ronald Brown · Quality Biological, Inc. · N01 · FY2013 · AI
University of Pittsburgh Clinical Trials Unit
$2,474,261John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2012 · AI
Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)
$2,474,236Gregory D Sempowski · Research Triangle Institute · U01 · FY2022 · AI
Optimizing malaria transmission-blocking vaccines with improved platforms
$2,473,905Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
CCR Genomics Core
$2,473,796Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised
$2,473,641Janko Nikolich-Zugich · Oregon Health & Science University · N01 · FY2009 · AI
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
$2,471,790Jennifer Lapek · Scripps Institution Of Oceanography · N01 · FY2023 · AI
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,471,663Stanford University · P01 · FY2004 · CA
ATN Coordinating Center
$2,471,565Craig M Wilson · University Of Alabama At Birmingham · U01 · FY2006 · HD
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,471,222Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Optical Technologies and Molecular Imaging for Cervical Neoplasia
$2,469,576Michele Follen · Texas Tech University Health Scis Center · P01 · FY2012 · CA
Task 7 (C29): Development of a Small Animal Model for Dengue
$2,469,186 · N01 · FY2009 · AI